The Use of Long-term Antibiotics in Bronchiectasis
Clinical Pulmonary Medicine, 03/02/2012Berry MPR et al.
Bronchiectasis is a chronic and debilitating lung disease characterized by chronic daily productive cough and recurrent chest infections caused by irreversibly damaged and dilated bronchi. The condition may be progressive and lead to respiratory failure and cor pulmonale. The management of bronchiectasis is largely empirical, with few controlled clinical trials. A recent National guideline suggests that in patients having ≥3 exacerbations per year the use of long–term antibiotic therapy should be considered.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.